[
  {
    "prevalence_id": "6",
    "orpha_code": "61",
    "disease_name": "Alpha-mannosidosis",
    "source": "7900112[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Not yet validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16658",
    "orpha_code": "166096",
    "disease_name": "Von Willebrand disease type 3",
    "source": "PMID: 6609712",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "86",
    "orpha_code": "583",
    "disease_name": "Mucopolysaccharidosis type 6",
    "source": "18681890[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "87",
    "orpha_code": "583",
    "disease_name": "Mucopolysaccharidosis type 6",
    "source": "18681890[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "157",
    "orpha_code": "881",
    "disease_name": "Turner syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 1999-2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "179",
    "orpha_code": "95",
    "disease_name": "Friedreich ataxia",
    "source": "1126051[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16703",
    "orpha_code": "586",
    "disease_name": "Cystic fibrosis",
    "source": "26795017[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16704",
    "orpha_code": "586",
    "disease_name": "Cystic fibrosis",
    "source": "26795017[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17741",
    "orpha_code": "307",
    "disease_name": "Juvenile myoclonic epilepsy",
    "source": "27861775[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "347",
    "orpha_code": "803",
    "disease_name": "Amyotrophic lateral sclerosis",
    "source": "21860251[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "348",
    "orpha_code": "803",
    "disease_name": "Amyotrophic lateral sclerosis",
    "source": "21860251[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "308",
    "orpha_code": "100",
    "disease_name": "Ataxia-telangiectasia",
    "source": "19339254[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "309",
    "orpha_code": "100",
    "disease_name": "Ataxia-telangiectasia",
    "source": "19339254[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "441",
    "orpha_code": "399",
    "disease_name": "Huntington disease",
    "source": "2938203[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "402",
    "orpha_code": "870",
    "disease_name": "Down syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": ">1 / 1000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5000.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "15893",
    "orpha_code": "790",
    "disease_name": "Retinoblastoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "491",
    "orpha_code": "580",
    "disease_name": "Mucopolysaccharidosis type 2",
    "source": "18681890[PMID]_[EXPERT]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "492",
    "orpha_code": "580",
    "disease_name": "Mucopolysaccharidosis type 2",
    "source": "18681890[PMID]_[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "508",
    "orpha_code": "579",
    "disease_name": "Mucopolysaccharidosis type 1",
    "source": "18681890[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "509",
    "orpha_code": "579",
    "disease_name": "Mucopolysaccharidosis type 1",
    "source": "18681890[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "575",
    "orpha_code": "906",
    "disease_name": "Wiskott-Aldrich syndrome",
    "source": "11202238[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Not yet validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "581",
    "orpha_code": "904",
    "disease_name": "Williams syndrome",
    "source": "12088082[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17537",
    "orpha_code": "904",
    "disease_name": "Williams syndrome",
    "source": "12088082[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16913",
    "orpha_code": "15",
    "disease_name": "Achondroplasia",
    "source": "32803853[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "650",
    "orpha_code": "394",
    "disease_name": "Homocystinuria due to cystathionine beta-synthase deficiency",
    "source": "15192637[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14414",
    "orpha_code": "673",
    "disease_name": "Malaria",
    "source": "European Centre for Disease prevention and Control 2013-2017[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "846",
    "orpha_code": "313",
    "disease_name": "Lamellar ichthyosis",
    "source": "9887377[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "976",
    "orpha_code": "3380",
    "disease_name": "Trisomy 18 syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "953",
    "orpha_code": "3378",
    "disease_name": "Trisomy 13 syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1258",
    "orpha_code": "2248",
    "disease_name": "Hypoplastic left heart syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2011[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1230",
    "orpha_code": "2140",
    "disease_name": "Congenital diaphragmatic hernia",
    "source": "EUROCAT European surveillance of congenital anomalies 2011[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1166",
    "orpha_code": "1880",
    "disease_name": "Ebstein malformation of the tricuspid valve",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1185",
    "orpha_code": "1915",
    "disease_name": "Fetal alcohol syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2009[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1365",
    "orpha_code": "660",
    "disease_name": "Omphalocele",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1366",
    "orpha_code": "660",
    "disease_name": "Omphalocele",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "15507",
    "orpha_code": "180275",
    "disease_name": "Paget disease of the nipple",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1306",
    "orpha_code": "2444",
    "disease_name": "Congenital pulmonary airway malformation",
    "source": "EUROCAT European surveillance of congenital anomalies 2011[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16883",
    "orpha_code": "716",
    "disease_name": "Phenylketonuria",
    "source": "32668217[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1563",
    "orpha_code": "166",
    "disease_name": "Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy",
    "source": "20482598[PMID]_4430158[PMID]_ ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "6-9 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Not yet validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 750.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17389",
    "orpha_code": "221",
    "disease_name": "Dermatomyositis",
    "source": "24695011[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16600",
    "orpha_code": "204",
    "disease_name": "Sporadic Creutzfeldt-Jakob disease",
    "source": "31876504[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16601",
    "orpha_code": "204",
    "disease_name": "Sporadic Creutzfeldt-Jakob disease",
    "source": "31876504[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "1679",
    "orpha_code": "581",
    "disease_name": "Mucopolysaccharidosis type 3",
    "source": "18681890[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1680",
    "orpha_code": "581",
    "disease_name": "Mucopolysaccharidosis type 3",
    "source": "18681890[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11700",
    "orpha_code": "685",
    "disease_name": "Hereditary spastic paraplegia",
    "source": "19339254[PMID]_24603320[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1670",
    "orpha_code": "216",
    "disease_name": "Neuronal ceroid lipofuscinosis",
    "source": "17092455[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1728",
    "orpha_code": "886",
    "disease_name": "Usher syndrome",
    "source": "3594933[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1709",
    "orpha_code": "791",
    "disease_name": "Retinitis pigmentosa",
    "source": "3594933[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1967",
    "orpha_code": "183",
    "disease_name": "Eosinophilic granulomatosis with polyangiitis",
    "source": "9805179[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11175",
    "orpha_code": "183",
    "disease_name": "Eosinophilic granulomatosis with polyangiitis",
    "source": "11760724[PMID]_25805746[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "16198",
    "orpha_code": "171901",
    "disease_name": "Primary cutaneous T-cell lymphoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16438",
    "orpha_code": "43",
    "disease_name": "X-linked adrenoleukodystrophy",
    "source": "23419472[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14462",
    "orpha_code": "810",
    "disease_name": "Shigellosis",
    "source": "European Centre for Disease prevention and Control 2011-2015[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1992",
    "orpha_code": "727",
    "disease_name": "Microscopic polyangiitis",
    "source": "11760724[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2010",
    "orpha_code": "900",
    "disease_name": "Granulomatosis with polyangiitis",
    "source": "11083271[PMID]_25805746[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2011",
    "orpha_code": "900",
    "disease_name": "Granulomatosis with polyangiitis",
    "source": "11760724[PMID]_11083271[PMID]_ ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1921",
    "orpha_code": "2368",
    "disease_name": "Gastroschisis",
    "source": "EUROCAT European surveillance of congenital anomalies 2011[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16321",
    "orpha_code": "797",
    "disease_name": "Sarcoidosis",
    "source": "5884453[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16322",
    "orpha_code": "797",
    "disease_name": "Sarcoidosis",
    "source": "5884453[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1896",
    "orpha_code": "1199",
    "disease_name": "Esophageal atresia",
    "source": "EUROCAT European surveillance of congenital anomalies 2011[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14248",
    "orpha_code": "1304",
    "disease_name": "Brucellosis",
    "source": "European Centre for Disease prevention and Control 2013-2017[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "14831",
    "orpha_code": "173",
    "disease_name": "Cholera",
    "source": "European Centre for Disease prevention and Control 2013-2017[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Class only",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 6.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "2213",
    "orpha_code": "3303",
    "disease_name": "Tetralogy of Fallot",
    "source": "EUROCAT European surveillance of congenital anomalies 2011[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2186",
    "orpha_code": "1209",
    "disease_name": "Tricuspid atresia",
    "source": "EUROCAT European surveillance of congenital anomalies 2011[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13411",
    "orpha_code": "3287",
    "disease_name": "Takayasu arteritis",
    "source": "27159262[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13412",
    "orpha_code": "3287",
    "disease_name": "Takayasu arteritis",
    "source": "27159262[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14211",
    "orpha_code": "549",
    "disease_name": "Legionnaires disease",
    "source": "European Centre for Disease prevention and Control 2013-2017[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17738",
    "orpha_code": "199318",
    "disease_name": "15q13.3 microdeletion syndrome",
    "source": "32778765[PMID]_ORPHANET",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2100",
    "orpha_code": "171",
    "disease_name": "Primary sclerosing cholangitis",
    "source": "9489916[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2101",
    "orpha_code": "171",
    "disease_name": "Primary sclerosing cholangitis",
    "source": "9489916[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14334",
    "orpha_code": "3299",
    "disease_name": "Tetanus",
    "source": "European Centre for Disease prevention and Control 2013-2017[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "2362",
    "orpha_code": "582",
    "disease_name": "Mucopolysaccharidosis type 4",
    "source": "18681890[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2363",
    "orpha_code": "582",
    "disease_name": "Mucopolysaccharidosis type 4",
    "source": "18681890[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2377",
    "orpha_code": "2137",
    "disease_name": "Autoimmune hepatitis",
    "source": "9489916[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2378",
    "orpha_code": "2137",
    "disease_name": "Autoimmune hepatitis",
    "source": "9489916[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16994",
    "orpha_code": "397",
    "disease_name": "Giant cell arteritis",
    "source": "31909871[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2425",
    "orpha_code": "2932",
    "disease_name": "Chronic inflammatory demyelinating polyneuropathy",
    "source": "11284994[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "15873",
    "orpha_code": "654",
    "disease_name": "Nephroblastoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14314",
    "orpha_code": "1489",
    "disease_name": "Whooping cough",
    "source": "European Centre for Disease prevention and Control 2013-2017[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12512",
    "orpha_code": "3389",
    "disease_name": "Tuberculosis",
    "source": "World Health Organization 2011[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14239",
    "orpha_code": "1267",
    "disease_name": "Botulism",
    "source": "European Centre for Disease prevention and Control 2011-2015[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "15915",
    "orpha_code": "449",
    "disease_name": "Hepatoblastoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "14389",
    "orpha_code": "533",
    "disease_name": "Listeriosis",
    "source": "European Centre for Disease prevention and Control 2012-2016[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17612",
    "orpha_code": "528",
    "disease_name": "Congenital generalized lipodystrophy",
    "source": "https://www.ncbi.nlm.nih.gov/books/NBK1212/",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2652",
    "orpha_code": "2014",
    "disease_name": "Cleft palate",
    "source": "EUROCAT European surveillance of congenital anomalies 2011[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "6-9 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 750.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2653",
    "orpha_code": "2014",
    "disease_name": "Cleft palate",
    "source": "EUROCAT European surveillance of congenital anomalies 2011[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "6-9 / 10 000",
    "qualification": "Class only",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 750.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2697",
    "orpha_code": "557",
    "disease_name": "Non-syndromic anorectal malformation",
    "source": "EUROCAT European surveillance of congenital anomalies 2011[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "15459",
    "orpha_code": "150",
    "disease_name": "Nasopharyngeal carcinoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8115",
    "orpha_code": "137914",
    "disease_name": "Choanal atresia",
    "source": "EUROCAT European surveillance of congenital anomalies 2011[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9103",
    "orpha_code": "250923",
    "disease_name": "Isolated aniridia",
    "source": "18494745[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3950",
    "orpha_code": "1848",
    "disease_name": "Renal agenesis, bilateral",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "15475",
    "orpha_code": "276145",
    "disease_name": "Malignant epithelial tumor of salivary glands",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4199",
    "orpha_code": "3384",
    "disease_name": "Common arterial trunk",
    "source": "EUROCAT European surveillance of congenital anomalies 2011[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11425",
    "orpha_code": "3388",
    "disease_name": "Neural tube defect",
    "source": "26601850[PMID]_EUROCAT European surveillance of congenital anomalies 1999-2011[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "6-9 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 750.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11616",
    "orpha_code": "206647",
    "disease_name": "Myotonic dystrophy",
    "source": "3263224[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "12345",
    "orpha_code": "3392",
    "disease_name": "Tularemia",
    "source": "26738841[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "15665",
    "orpha_code": "213504",
    "disease_name": "Adenocarcinoma of ovary",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "15573",
    "orpha_code": "213557",
    "disease_name": "Salivary gland type cancer of the breast",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "15556",
    "orpha_code": "213531",
    "disease_name": "Metaplastic carcinoma of the breast",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "15529",
    "orpha_code": "213528",
    "disease_name": "Rare adenocarcinoma of the breast",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4602",
    "orpha_code": "3189",
    "disease_name": "Congenital pulmonary valvar stenosis",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "15589",
    "orpha_code": "213716",
    "disease_name": "Squamous cell carcinoma of the corpus uteri",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "15647",
    "orpha_code": "213772",
    "disease_name": "Adenocarcinoma of the cervix uteri",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "15619",
    "orpha_code": "213767",
    "disease_name": "Squamous cell carcinoma of the cervix uteri",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8735",
    "orpha_code": "216675",
    "disease_name": "Transposition of the great arteries",
    "source": "EUROCAT European surveillance of congenital anomalies 2011[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4642",
    "orpha_code": "882",
    "disease_name": "Tyrosinemia type 1",
    "source": "20301688[PMID]_22554029[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Not yet validated",
    "reliability_score": 6.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4525",
    "orpha_code": "767",
    "disease_name": "Polyarteritis nodosa",
    "source": "9805179[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4527",
    "orpha_code": "767",
    "disease_name": "Polyarteritis nodosa",
    "source": "ORPHANET",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Not yet validated",
    "reliability_score": 4.5,
    "is_fiable": false,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "4515",
    "orpha_code": "3162",
    "disease_name": "Sézary syndrome",
    "source": "18808419[PMID]_ ORPHANET_[EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "14359",
    "orpha_code": "340",
    "disease_name": "Hemorrhagic fever-renal syndrome",
    "source": "European Centre for Disease prevention and Control 2011-2015[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4565",
    "orpha_code": "1457",
    "disease_name": "Aorta coarctation",
    "source": "EUROCAT European surveillance of congenital anomalies 2011[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16134",
    "orpha_code": "94",
    "disease_name": "Astrocytoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16112",
    "orpha_code": "1501",
    "disease_name": "Adrenocortical carcinoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16157",
    "orpha_code": "391",
    "disease_name": "Classic Hodgkin lymphoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "10731",
    "orpha_code": "1172",
    "disease_name": "Autosomal recessive cerebellar ataxia",
    "source": "19339254[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4805",
    "orpha_code": "2073",
    "disease_name": "Narcolepsy type 1",
    "source": "19456307[PMID]_24849861[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4791",
    "orpha_code": "809",
    "disease_name": "Mixed connective tissue disease",
    "source": "21398332[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4792",
    "orpha_code": "809",
    "disease_name": "Mixed connective tissue disease",
    "source": "21398332[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "15996",
    "orpha_code": "370334",
    "disease_name": "Extraskeletal Ewing sarcoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "4967",
    "orpha_code": "823",
    "disease_name": "Spina bifida and other spinal dysraphisms",
    "source": "EUROCAT European surveillance of congenital anomalies 2011[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "15811",
    "orpha_code": "363489",
    "disease_name": "Sex cord-stromal tumor of testis",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "4994",
    "orpha_code": "829",
    "disease_name": "Adult-onset Still disease",
    "source": "16467042[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4995",
    "orpha_code": "829",
    "disease_name": "Adult-onset Still disease",
    "source": "16467042[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "13872",
    "orpha_code": "289390",
    "disease_name": "Primary Sjögren disease",
    "source": "21231797[PMID]_25387476[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "9637",
    "orpha_code": "281097",
    "disease_name": "Autosomal recessive congenital ichthyosis",
    "source": "9887377[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16042",
    "orpha_code": "300385",
    "disease_name": "Pituitary carcinoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "15252",
    "orpha_code": "401920",
    "disease_name": "Fibrolamellar hepatocellular carcinoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "15834",
    "orpha_code": "398058",
    "disease_name": "Squamous cell carcinoma of the penis",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "15853",
    "orpha_code": "398053",
    "disease_name": "Adenocarcinoma of the penis",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "15756",
    "orpha_code": "398987",
    "disease_name": "Malignant teratoma of ovary",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "15684",
    "orpha_code": "398961",
    "disease_name": "Mucinous adenocarcinoma of ovary",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "15711",
    "orpha_code": "398971",
    "disease_name": "Clear cell adenocarcinoma of the ovary",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14960",
    "orpha_code": "418959",
    "disease_name": "Squamous cell carcinoma of the stomach",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "14936",
    "orpha_code": "418951",
    "disease_name": "Undifferentiated carcinoma of esophagus",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "15206",
    "orpha_code": "424065",
    "disease_name": "Pancreatic solid pseudopapillary neoplasm",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "15193",
    "orpha_code": "424058",
    "disease_name": "Intraductal papillary mucinous carcinoma of pancreas",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "15126",
    "orpha_code": "424016",
    "disease_name": "Adenocarcinoma of the anal canal",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "15104",
    "orpha_code": "424019",
    "disease_name": "Squamous cell carcinoma of the anal canal",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "15147",
    "orpha_code": "424039",
    "disease_name": "Squamous cell carcinoma of pancreas",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "15167",
    "orpha_code": "424046",
    "disease_name": "Acinar cell carcinoma of pancreas",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "15038",
    "orpha_code": "423968",
    "disease_name": "Squamous cell carcinoma of the small intestine",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "15060",
    "orpha_code": "423994",
    "disease_name": "Squamous cell carcinoma of the colon",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "15082",
    "orpha_code": "424002",
    "disease_name": "Squamous cell carcinoma of the rectum",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "14994",
    "orpha_code": "423786",
    "disease_name": "Undifferentiated carcinoma of stomach",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "15275",
    "orpha_code": "424943",
    "disease_name": "Adenocarcinoma of the liver and intrahepatic biliary tract",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "15295",
    "orpha_code": "424970",
    "disease_name": "Undifferentiated carcinoma of liver and intrahepatic biliary tract",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "15347",
    "orpha_code": "424996",
    "disease_name": "Squamous cell carcinoma of gallbladder and extrahepatic biliary tract",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "15312",
    "orpha_code": "424975",
    "disease_name": "Squamous cell carcinoma of liver and intrahepatic biliary tract",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "15328",
    "orpha_code": "424982",
    "disease_name": "Biliary cystadenocarcinoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "5402",
    "orpha_code": "30391",
    "disease_name": "Isolated biliary atresia",
    "source": "EUROCAT European surveillance of congenital anomalies 2011[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16222",
    "orpha_code": "544",
    "disease_name": "Diffuse large B-cell lymphoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16246",
    "orpha_code": "545",
    "disease_name": "Follicular lymphoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14434",
    "orpha_code": "781",
    "disease_name": "Q fever",
    "source": "European Centre for Disease prevention and Control 2012-2016[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "5268",
    "orpha_code": "877",
    "disease_name": "Neuroendocrine neoplasm",
    "source": "18853416[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16088",
    "orpha_code": "143",
    "disease_name": "Parathyroid carcinoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "5171",
    "orpha_code": "889",
    "disease_name": "Cutaneous small vessel vasculitis",
    "source": "9805179[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17282",
    "orpha_code": "71277",
    "disease_name": "Classic glucose transporter type 1 deficiency syndrome",
    "source": "32913944[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14848",
    "orpha_code": "70482",
    "disease_name": "Carcinoma of esophagus",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6019",
    "orpha_code": "70476",
    "disease_name": "Vernal keratoconjunctivitis",
    "source": "18356259[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "11727",
    "orpha_code": "79213",
    "disease_name": "Mucopolysaccharidosis",
    "source": "18681890[PMID]_26586959[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17055",
    "orpha_code": "79140",
    "disease_name": "Cutaneous neuroendocrine carcinoma",
    "source": "33932460[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "15740",
    "orpha_code": "35808",
    "disease_name": "Malignant sex cord stromal tumor of ovary",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "15777",
    "orpha_code": "35807",
    "disease_name": "Malignant germ cell tumor of ovary",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "5543",
    "orpha_code": "35858",
    "disease_name": "Imerslund-Gräsbeck syndrome",
    "source": "Pr Ralph GRÄSBECK[EXPERT]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16014",
    "orpha_code": "33276",
    "disease_name": "Kaposi sarcoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "5485",
    "orpha_code": "34515",
    "disease_name": "FKRP-related limb-girdle muscular dystrophy R9",
    "source": "20961759[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16645",
    "orpha_code": "89936",
    "disease_name": "X-linked hypophosphatemia",
    "source": "PMID: 26543054",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 8.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "15233",
    "orpha_code": "88673",
    "disease_name": "Hepatocellular carcinoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7099",
    "orpha_code": "91378",
    "disease_name": "Hereditary angioedema",
    "source": "11202238[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6561",
    "orpha_code": "79473",
    "disease_name": "Variegate porphyria",
    "source": "23114748[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "6562",
    "orpha_code": "79473",
    "disease_name": "Variegate porphyria",
    "source": "23114748[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6419",
    "orpha_code": "79278",
    "disease_name": "Autosomal erythropoietic protoporphyria",
    "source": "23114748[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "6422",
    "orpha_code": "79278",
    "disease_name": "Autosomal erythropoietic protoporphyria",
    "source": "23114748[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6396",
    "orpha_code": "79276",
    "disease_name": "Acute intermittent porphyria",
    "source": "23114748[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "6397",
    "orpha_code": "79276",
    "disease_name": "Acute intermittent porphyria",
    "source": "23114748[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17214",
    "orpha_code": "85443",
    "disease_name": "AL amyloidosis",
    "source": "35854312[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17215",
    "orpha_code": "85443",
    "disease_name": "AL amyloidosis",
    "source": "35854312[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16182",
    "orpha_code": "86893",
    "disease_name": "Nodular lymphocyte predominant Hodgkin lymphoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "6688",
    "orpha_code": "85138",
    "disease_name": "Addison disease",
    "source": "12072049[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "15951",
    "orpha_code": "99757",
    "disease_name": "Embryonal rhabdomyosarcoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "15976",
    "orpha_code": "99756",
    "disease_name": "Alveolar rhabdomyosarcoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "<1 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 0.5,
    "confidence_level": "medium",
    "estimate_source": "class_estimate"
  },
  {
    "prevalence_id": "14114",
    "orpha_code": "98879",
    "disease_name": "Hemophilia B",
    "source": "21649801[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7653",
    "orpha_code": "98878",
    "disease_name": "Hemophilia A",
    "source": "19845775[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7763",
    "orpha_code": "98976",
    "disease_name": "Congenital glaucoma",
    "source": "EUROCAT European surveillance of congenital anomalies 2000-2016[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7478",
    "orpha_code": "98555",
    "disease_name": "Microphthalmia-anophthalmia-coloboma",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7479",
    "orpha_code": "98555",
    "disease_name": "Microphthalmia-anophthalmia-coloboma",
    "source": "EUROCAT European surveillance of congenital anomalies 2010[REG]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Class only",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7516",
    "orpha_code": "98723",
    "disease_name": "Hypoplastic right heart syndrome",
    "source": "EUROCAT European surveillance of congenital anomalies 2011[REG]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "15018",
    "orpha_code": "104075",
    "disease_name": "Adenocarcinoma of the small intestine",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8028",
    "orpha_code": "101997",
    "disease_name": "Primary immunodeficiency",
    "source": "11202238[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8023",
    "orpha_code": "101330",
    "disease_name": "Porphyria cutanea tarda",
    "source": "19233912[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8003",
    "orpha_code": "101081",
    "disease_name": "Charcot-Marie-Tooth disease type 1A",
    "source": "20482598[PMID]_24646194[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "6-9 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 750.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7948",
    "orpha_code": "100980",
    "disease_name": "Autosomal dominant pure spastic paraplegia",
    "source": "22554690[PMID]_ORPHANET",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Not yet validated",
    "reliability_score": 7.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7946",
    "orpha_code": "100979",
    "disease_name": "Autosomal dominant complex spastic paraplegia",
    "source": "19339254[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16066",
    "orpha_code": "100088",
    "disease_name": "Rare thyroid carcinoma",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14871",
    "orpha_code": "99977",
    "disease_name": "Squamous cell carcinoma of the esophagus",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14895",
    "orpha_code": "99976",
    "disease_name": "Adenocarcinoma of the oesophagus and oesophagogastric junction",
    "source": "RARECARE surveillance of rare cancers in Europe[REG]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14280",
    "orpha_code": "99828",
    "disease_name": "Dengue fever",
    "source": "European Centre for Disease prevention and Control 2013-2017[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "Norway",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  }
]